Skip to content

Postoperative Sedation After Cardiac Surgery

Postoperative Sedation After Cardiac Surgery: Pilot Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02488486
Acronym
SEDCAR
Enrollment
19
Registered
2015-07-02
Start date
2015-05-31
Completion date
2017-05-31
Last updated
2017-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Surgery, Cardiac

Brief summary

This pilot study evaluates the effectiveness of a closed-loop administration of propofol and remifentanil guided by the bispectral index for short-term sedation after cardiac surgery.

Interventions

DEVICEAutomated postoperative sedation
DRUGpropofol
DRUGremifentanil

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* consent for participation * cardiac surgical procedure requiring postoperative sedation

Exclusion criteria

* pregnant women, * neurological or muscular disorder * high risk of revision surgery * patients having required a redo operation if the postoperative period of sedation was less than 2 hours

Design outcomes

Primary

MeasureTime frameDescription
Level of sedation6 hoursRichmond Agitation-Sedation Scale measured until extubation

Secondary

MeasureTime frameDescription
Changes in hemodynamics profile consecutive to a tracheal suctioning6 hours
Changes in Bispectral Index consecutive to a tracheal suctioning6 hours
Changes in Richmond Agitation-Sedation Scale consecutive to a tracheal suctioning6 hours
Changes in Behavioral Pain Scale consecutive to a tracheal suctioning6 hours
Changes in concentration of propofol consecutive to a tracheal suctioning6 hours
Changes in concentration of remifentanil consecutive to a tracheal suctioning6 hours
Delay before awakening6 hoursDelay between the cessation of infusion of propofol and remifentanil and extubation.
Number of temporary or definitive interruptions of the automated administration of propofol and remifentanil6 hours
Calculation of indices of performance of the closed-loop system6 hours
Level of pain during sedation6 hoursBehavioral Pain Scale measured until extubation
Total amounts of propofol observed during sedation period6 hours
Total amounts of remifentanil observed during sedation period6 hours
Changes in calculated plasma concentrations of propofol including minimum concentrations and maximum values6 hours
Changes in calculated plasma concentrations of remifentanil including minimum concentrations and maximum values.6 hours
Hemodynamic status during the sedation period6 hoursEvolution of hemodynamic parameters (composite)
Level of consciousness after extubation6 hoursRichmond Agitation-Sedation Scale assessed every hour for three hours after extubation
Pain after extubation6 hoursSimple numerical scale from 0 (no pain) to 10 (worst possible) assessed every hour for three hours after extubation
Awareness standardized questionnaire48 hours
Periods of electrical silence6 hoursNumber and duration of electroencephalographic periods of silence

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026